breast cancer consumers to remain the most common cancer diagnosed in women in the united

states and is the same leading cause of cancer that in women

the current lifetime risk of a woman developing breast cancer is one and eight or

twelve point three percent

several breast cancer risk factors have been identified over the years

some of them up modifiable while others are not

the objective of this review is just summarize the vector strategies directed at reducing the

risk of breast cancer which are in thilo's an integrated approach in one thing identification

of high risk women if a screening reference as well as nutritional pharmacological and surgical

management

so risk assessment tools the most common being together model

clinicians determine the quantitative risk of breast cancer

the role of selective oestrogen receptor modulator to marks the fan and scheme documented in

change was established by several clinical trials

such as the and f a b p one trial

subsequently we lost if we also emerge as an option to emox of an with

this reduction in the incidence of breast cancer reported in the star trial

currently the united states to mark the fan

and velocity are f t approved for this indication

more recently a little bit ace inhibitors such as x m s t and announced

result were shown to reduce the incidence of breast cancer in the map three and

i was to trials respectively and may serve as an alternative to the selected oestrogen

receptor modulator is what about to be favourable side effect profile

the potential adverse effects of the schema preventive agents such as individual high publisher and

trombone body disease with a marks the phone or a structure as hot flashes and

all stripper roses with a limiting is inhibitors must be discussed with the patient before

deciding on this approach

it is estimated that over two million women in the united states could benefit from

cuba prevention to reduce the risk of breast cancer however in reality it's uses rather

limited possible explanations the disinclude

difficulties identifying the ideal candidates for this approach

decreased awareness amongst health care providers

and high risk women and concerns about the potential adverse effects in the absence of

the diagnosed cancer

identifying the optimal candidate speaking about prevention strategies

and it is to be challenging

is the existing breast cancer risk assessment models do not incorporate or non risk factors

for breast cancer and there is a significant variability in the overall design and points

and inclusion criteria across clinical trials

although there is no conclusive evidence to suggest the protective role of specific directory components

alcohol consumption

and obesity are associated with an increased breast cancer risk does lifestyle changes can you

to a lower risk of developing breast cancer

such approaches including bilateral risk reduction mastectomy

and starting correctable

i usually limited to agreement with the red terry predisposition to developing breast scan